These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis. Sanna MD, Quattrone A, Galeotti N. Neuropharmacology; 2017 Sep 01; 123():116-125. PubMed ID: 28599923 [Abstract] [Full Text] [Related]
3. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Sloane E, Ledeboer A, Seibert W, Coats B, van Strien M, Maier SF, Johnson KW, Chavez R, Watkins LR, Leinwand L, Milligan ED, Van Dam AM. Brain Behav Immun; 2009 Jan 01; 23(1):92-100. PubMed ID: 18835435 [Abstract] [Full Text] [Related]
9. In-Depth Characterization of Somatic and Orofacial Sensitive Dysfunctions and Interfering-Symptoms in a Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mouse Model. Démosthènes A, Sion B, Giraudet F, Moisset X, Daulhac L, Eschalier A, Bégou M. Front Neurol; 2021 Sep 01; 12():789432. PubMed ID: 35111128 [Abstract] [Full Text] [Related]
10. Altered cognitive-emotional behavior in early experimental autoimmune encephalitis--cytokine and hormonal correlates. Acharjee S, Nayani N, Tsutsui M, Hill MN, Ousman SS, Pittman QJ. Brain Behav Immun; 2013 Oct 01; 33():164-72. PubMed ID: 23886782 [Abstract] [Full Text] [Related]
11. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain. Khan N, Kuo A, Brockman DA, Cooper MA, Smith MT. Inflammopharmacology; 2018 Feb 01; 26(1):77-86. PubMed ID: 28965161 [Abstract] [Full Text] [Related]
15. Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D. J Neuroinflammation; 2016 Sep 02; 13(1):231. PubMed ID: 27589957 [Abstract] [Full Text] [Related]
16. Elevated serum [Met5]-enkephalin levels correlate with improved clinical and behavioral outcomes in experimental autoimmune encephalomyelitis. Ludwig MD, Zagon IS, McLaughlin PJ. Brain Res Bull; 2017 Sep 02; 134():1-9. PubMed ID: 28647454 [Abstract] [Full Text] [Related]
17. Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the dark agouti rat model of experimental autoimmune encephalomyelitis. Iglesias-Bregna D, Hanak S, Ji Z, Petty M, Liu L, Zhang D, McMonagle-Strucko K. J Pharmacol Exp Ther; 2013 Oct 02; 347(1):203-11. PubMed ID: 23892570 [Abstract] [Full Text] [Related]
18. TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis. Dalenogare DP, Theisen MC, Peres DS, Fialho MFP, Lückemeyer DD, Antoniazzi CTD, Kudsi SQ, Ferreira MA, Ritter CDS, Ferreira J, Oliveira SM, Trevisan G. Exp Neurol; 2020 Jun 02; 328():113241. PubMed ID: 32045597 [Abstract] [Full Text] [Related]
19. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production. Li F, Fang L, Huang S, Yang Z, Nandi J, Thomas S, Chen C, Camporesi E. Anesth Analg; 2011 Sep 02; 113(3):626-33. PubMed ID: 21596875 [Abstract] [Full Text] [Related]
20. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis. Potter LE, Paylor JW, Suh JS, Tenorio G, Caliaperumal J, Colbourne F, Baker G, Winship I, Kerr BJ. J Neuroinflammation; 2016 Jun 10; 13(1):142. PubMed ID: 27282914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]